Cell Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2024-09-19 ms4000000962704650 来自江西省

请问一下Cell Rep跟JECCR，选哪一个好

39 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2024-04-30 darktempler 来自江苏省

说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！

128 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2025-02-16 1250caacm11暂无昵称来自山东省

请问是否需要那个作者确认？

14 0

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2023-06-14 ms7000001335611101 来自天津

偏重的研究方向：医学;肿瘤
经验分享：请问under review是送审了吗？为什么没收到邮件呢

156 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2023-06-14 ms7000001335611101 来自天津

偏重的研究方向：医学;肿瘤
经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢

164 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2024-12-04 147f2cd9m92暂无昵称来自北京

即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好

25 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2024-07-15 沧海医僧笑来自重庆

with editor都12天了都还没更新状态，正常不呢

105 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2024-11-06 ms3000002012222276 来自宁夏

审稿快吗

32 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2019-03-07 tjyrzlk

18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。

465 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2226589, encodeId=ee43222658985, content=请问一下Cell Rep跟JECCR，选哪一个好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c4c05433377, createdName=ms4000000962704650, createdTime=Thu Sep 19 15:39:00 CST 2024, time=2024-09-19, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2201197, encodeId=ecba220119e7a, content=说一下自己的被坑遭遇，投了cell reports，一审被拒，然后argue后给了大修，二审被拒，三个审稿人，二审时另外两个都没意见了，就被其中一个审稿人给恶心了。我做的是蛋白的乳酸化修饰机制，通用的做法都是把赖氨酸(K)突变成精氨酸（R）来模拟去修饰状态，这个审稿人就是不认可，第一次拒稿也是因为他质疑这个氨基酸突变模拟，如果他不认可这个氨基酸突变的模拟，那我所有的工作就都是空中楼阁了。不谈其他杂志了，cell主刊都发了好几篇乳酸化修饰的文章了，都是这么做的，并且我的文章还排除了这个位点其他可能存在的占主导优势的赖氨酸酰化修饰，cell文章里都没我这么严谨！这些编辑没点自己的判断吗，就这么维护审稿人的傻逼意见，真的很无语！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Tue Apr 30 09:44:30 CST 2024, time=2024-04-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2252190, encodeId=eb1e225219097, content=请问是否需要那个作者确认？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70d82534981, createdName=1250caacm11暂无昵称, createdTime=Sun Feb 16 14:42:55 CST 2025, time=2025-02-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2142783, encodeId=54ee2142e83cc, content=偏重的研究方向：医学;肿瘤 经验分享：请问under review是送审了吗？为什么没收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 19:05:14 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2142803, encodeId=afcd2142803d4, content=偏重的研究方向：医学;肿瘤 经验分享：请问各位前辈，under review代表送审了吗？为什么没有收到邮件呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7de85684843, createdName=ms7000001335611101, createdTime=Wed Jun 14 22:11:10 CST 2023, time=2023-06-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2240785, encodeId=82a82240e85ca, content=即时影响因子5.83，为什么一直在降呢，上边的文章质量都很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=39875256687, createdName=147f2cd9m92暂无昵称, createdTime=Wed Dec 04 15:25:04 CST 2024, time=2024-12-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2214992, encodeId=23d1221499279, content=with editor都12天了都还没更新状态，正常不呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f4d02501413, createdName=沧海医僧笑, createdTime=Mon Jul 15 10:10:53 CST 2024, time=2024-07-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2235470, encodeId=e9d922354e03d, content=审稿快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90a19450843, createdName=ms3000002012222276, createdTime=Wed Nov 06 09:57:08 CST 2024, time=2024-11-06, status=1, ipAttribution=宁夏), GetPortalCommentsPageByObjectIdResponse(id=567730, encodeId=8e3a56e73061, content=18年五月投，with editor四天，review三周，回来reject但可以写补实验计划，编辑看完计划再决定是否给返修的机会。三个审稿人十三页意见，一条一条写答复和计划，一周后提交计划，三天内编辑把状态改成revise。然后漫长的补实验，有很多动物实验补了789三个月实验又修回去。审稿两周回来三个人一个人没问题，另两个人每个人还一个关键问题，安排了一下，等老鼠等了俩月，一月份补一个月，又修回去。三天后pre－accept。之后完全按照cell系列把star method等部分修改答到要求，官方2月accept。oa费用5000刀，二月之后变5200刀，和nc看齐。。。总得说分数不是很高，但认可度还不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=465, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhYMJhrc5pOOkzDL5OZxtJXF8bIMN771S3sGM7ibiasFulqr1BpdnvvjsQd0AUJabaHqm8AfqHScPe3/0, createdBy=f5721980518, createdName=tjyrzlk, createdTime=Thu Mar 07 00:00:00 CST 2019, time=2019-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224046, encodeId=a58e12240467c, content=年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=252, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:00:38 CST 2022, time=2022-06-02, status=1, ipAttribution=)]

2022-06-02 cindichaw

年初接收了一篇。因为顶刊大子刊，SA,NC之类的冲上不去，工作量挺大的，发了cell rep。感觉略亏了，但杂志声望和评审细致都还可以。

252 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务